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Abstract
We previously reported that neuraminidase (NA) pretreatment of human PBMCs markedly increased their cytokine response
to lipopolysaccharide (LPS). To study the mechanisms by which this occurs, we transfected HEK293T cells with plasmids
encoding TLR4, CD14, and MD2 (three components of the LPS receptor complex), as well as a NFkB luciferase reporting
system. Both TLR4 and MD2 encoded by the plasmids are a-2,6 sialylated. HEK293T cells transfected with TLR4/MD2/CD14
responded robustly to the addition of LPS; however, omission of the MD2 plasmid abrogated this response. Addition of
culture supernatants from MD2 (sMD2)-transfected HEK293T cells, but not recombinant, non-glycosylated MD2
reconstituted this response. NA treatment of sMD2 enhanced the LPS response as did NA treatment of the TLR4/CD14-
transfected cell supplemented with untreated sMD2, but optimal LPS-initiated responses were observed with NA-treated
TLR4/CD14-transfected cells supplemented with NA-treated sMD2. We hypothesized that removal of negatively charged
sialyl residues from glycans on the TLR4 complex would hasten the dimerization of TLR4 monomers required for signaling.
Co-transfection of HEK293T cells with separate plasmids encoding either YFP- or FLAG-tagged TLR4, followed by treatment
with NA and stimulation with LPS, led to an earlier and more robust time-dependent dimerization of TLR4 monomers on co-
immunoprecipitation, compared to untreated cells. These findings were confirmed by fluorescence resonance energy
transfer (FRET) analysis. Overexpression of human Neu1 increased LPS-initiated TLR4-mediated NFkB activation and a NA
inhibitor suppressed its activation. We conclude that (1) sialyl residues on TLR4 modulate LPS responsiveness, perhaps by
facilitating clustering of the homodimers, and that (2) sialic acid, and perhaps other glycosyl species, regulate MD2 activity
required for LPS-mediated signaling. We speculate that endogenous sialidase activity mobilized during cell activation may
play a role in this regulation.
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Introduction
Eukaryotic hosts can distinguish between ‘‘self’’ antigens and
potential exogenous or endogenous ‘‘danger signals’’ through the
expression of pattern recognition receptors (PRRs) on their cell
surface and/or within the cell cytosol. Among the families of
PRRs, the Toll-like receptors (TLRs) are the most well studied,
with 10 distinct TLRs expressed on human cells and 12 on murine
cells [1]. Poltarak et al identified TLR4 as the receptor for Gram-
negative bacterial lipopolysaccharide (LPS), thereby characterizing
the basis for the previously recognized resistance of C3H/HeJ and
C57BL6/ScN mice to LPS lethality [2]. In the absence of a
functional TLR4, these mice are unable to recognize LPS or to
initiate a pro-inflammatory response. While the failure to
recognize and initiate an intracellular signaling cascade may
protect mice from lethal LPS intoxication, we and others have
shown that such a signaling defect makes these mice highly
susceptible to lethal bacterial infection [3,4]. Thus, TLR4-initiated
responses are required for host defenses against live, replicating
bacterial infection, but may lead to deleterious responses as well.
Subsequent studies have clearly established that while TLR4
recognizes LPS, it requires the presence of an adapter protein,
MD-2, and an accessory molecule, CD14, for its function [5].
These three proteins form the TLR4 receptor complex. Further,
each of these proteins must be glycosylated for their proper
function [6], but neither the required carbohydrate moieties nor a
putative mechanism for their regulation has been identified.
Glycosylation of molecules on the cell surface regulates their
interaction with ligands, such as insulin, and with other
glycoconjugates on the cell surface as well as determines the
ability of the cell to interact with other cells during inflammation
[7] . In part through its negative charge, terminal sialyl residues
may modulate these molecular and cellular interactions [7–10].
Our laboratory has studied the role of sialic acid modulation in
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sialidase activity in human polymorphonuclear leukocytes (PMN)
resides within intracellular compartments, primarily secondary
granules, and upon PMN activation, the sialidase activity
translocates to the PMN surface where it becomes an integral
membrane protein [11]. This enzyme may then remove sialyl
residues from glycoconjugates on its own (i.e. autocrine) or
adjacent (paracrine) cells. These cells become more motile,
adhesive and more responsive to subsequent agonist stimulation
[12]. Inhibition of PMN sialidase activity inhibits their recruitment
to inflammatory sites in response to IL-8 in vivo and their
transendothelial migration to chemokines in vitro [13]. Once at an
inflammatory site, the removal of sialyl residues on the PMN b2
integrin and endothelial cell ICAM-1 exposes activation epitopes
on each molecule that enhances their binding interaction [14]. In
addition, restoration of sialylation on the PMN surface by a PMN
sialyltransferase restores the non-activated phenotype [15]. Thus,
the PMN can orchestrate its activation phenotype by modulating
the sialylation at its cell surface through the activity of endogenous
sialidase and sialyltransferase activities.
Modulation of sialic acid content on the surface of human
peripheral blood mononuclear cells (PBMC) also affects their
immune capacity. Pretreatment of PBMCs with an exogenous
sialidase (Clostridium perfringens) markedly enhances the subsequent
production of cytokines in response to LPS [16]. Inhibition of
endogenous sialidase activity in monocyte-derived dendritic cells
decreases LPS-induced cytokine production [17]. Since the TLR4
complex is the principal PRR for LPS, we reasoned that TLR4 is
sialylated, and that removal of sialyl residues facilitates the
recognition of LPS by this receptor complex and/or enhances
subsequent downstream signaling. In the present studies, we
demonstrate that not only TLR4 but also MD-2 is sialylated, and
that removal of sialyl residues on each of these molecules enhances
the functional response of cells to LPS.
Materials and Methods
Cell line and reagents
HEK293T human embryonic kidney cells (American Type
Culture Collection) were cultured in DMEM (Invitrogen,
Carlsbad, CA) supplemented with 10% FBS, 2 mM L-glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin all from
Invitrogen. LPS (E. coli O111B4) was purchased from List
Biologics (Campbell, CA). C. perfringens neuraminidase (Type X),
anti-FLAG (MD2) antibody, and protein A agarose was purchased
from Sigma (St. Louis, MO). The neuraminidase inhibitor, 2,3-
Dehydro-2-deoxy-N-acetyl neuraminic acid (2-DN) and a control
of similar MW and charge, 2-keto-3-deoxyoctulonic acid (KDO),
were purchased from Calbiochem (Gibbstown, NJ). Anti-GFP was
purchased from Invitrogen. TurboFect transfection reagent was
purchased from Fermentas (Glen Burnie, MD); SuperFect
transfection reagent was purchased from Qiagen (Valencia, CA).
Recombinant human MD-2, recombinant human TLR4/MD2
complex, each fused to a polyhistidine tag, and recombinant
human CD14 were purchased from R&D Systems, Inc.
(Minneapolis MN)
Plasmid construction
Except for pcDNA-TLR4-CFP, all expression plasmids were
constructed as previously reported [18] and were prepared using
EndoFree Plasmid Maxi kit (Qiagen). To construct the pcDNA-
TLR4-CFP plasmid, the YFP fragment was excised from pcDNA-
TLR4-YFP and replaced with CFP, which was isolated from
pcDNA3-CFP (Addgene, Cambridge, MA) after restriction enzyme
digestion. TLR4 glycosylation mutants have been generated by
introducing the respective mutations N35A, N173A, N205A or
their combinations, into pcDNA3-TLR4-YFP expression plasmid
by PCR-based site-directed mutagenesis, as described [19–21],
using the following primers: N35A, 59-TGCGTGGAGG-
TGGTTCCTGCTATTACTTATCAAT GCATGGAGCTG-39;
N173A; 59-TCAAATTACCTGAGTATTTTTCTGC TCTGA-
CC AATCTAGAGCACTTGG-39; N205A, 59-GTTCTACAT-
CAAATGCCCCTACTCGCTCTCTCTTTAGACCTGTCCC-
TG-39. pcDNA3-TLR4-YFP P416A expression plasmid has been
described [22].
Nucleotide sequencing (Genomic and Biopolymer Core Facility,
University of Maryland, Baltimore, MD) of each construct was
carried out to confirm the specific and correct introduction of the
mutations and the absence of PCR-introduced errors.
Transfection and Reporter assay
Transfection and reporter assays were performed as described
previously [18]. Briefly, HEK293T cells were seeded onto 24-well
plates (2610
5 cells/well) and incubated overnight. The cells were
co-transfected with optimized amounts of plasmid mixture
containing pcDNA3-TLR4-YFP, pcDNA3-huCD14, pEFBOS-
MD2-FLAG, pELAM-luc (NF-kB Luciferase reporter), and
pcDNA-renilla. After 20 h of recovery, cells were stimulated with
LPS at the indicated concentrations overnight, and lysed in 16
reporter assay lysis buffer (Promega, Madison, WI). Firefly and
renilla luciferase activities were assayed at LMax II
384 microplate
reader (Molecular Devices, Sunnyvale, CA) with injection of
100 ml of substrate from Luciferase Assay System or Renilla
Luciferase Assay System individually (Promega). ‘‘Relative lucif-
erase activity’’ was calculated by normalizing each sample’s firefly
luciferase activity to constitutive renilla luciferase activity mea-
sured within the same sample, and was represented as relative
luciferase units (RLU). In some experiments, 2-DN (250 ug/ml) or
KDO (250 ug/ml) were added to the medium during culture.
In reconstitution cultures, HEK293T cells were co-transfected
with the above plasmid mixture without pcDNA3-MD2-FLAG,
and supplemented with supernatant (SNT) from MD2-transfected
HEK293T cell before LPS stimulation, as previously described
[23]. For desialylation, cells were treated with C. perfringens
neuraminidase (NA) (30 mU/ml) for 1 hour in PBS before LPS
stimulation. SNT from MD2-transfected cells (sMD2) was treated
with NA-agarose beads (Sigma) for one hour and separated with
centrifugation. PBS and/or heat-inactivated NA were used as
controls. For heat inactivation, NA or NA agarose was boiled for
30 minutes. Complete inactivation was confirmed in a sialidase
activity assay.
Transfection and Immunoprecipitation
HEK293T cells were seeded into 90-mm cell culture dishes at
10
6 cells/mL in 5 mL of complete media, and incubated at 37uC
in 5% CO2 overnight. Cells were transfected with 10 mgo f
plasmid mixture using TurboFect (Fermentas) or SuperFect
(Qiagen) transfection reagent according to the manufacturer’s
recommendation. Complete media was replaced after 4–6 h. Cells
were scraped and harvested 72 h after transfection, washed in
HBSS and lysed using 16Lysis Buffer (Cell Signaling Technology)
containing protease inhibitors (Roche).
The cell lysates containing the proteins of interest were
incubated with pre-cleaned Protein A agarose beads (Sigma) for
2 h at 4uC on a roller. Samples were spun down and anti-GFP
antibody (Invitrogen) or anti-FLAG antibody (Sigma) was added
to the supernatants (2 mg/mL) and incubated at 4uC for 4–6 h.
Freshly cleared Protein A agarose beads were then added to each
Desialylation Enhances LPS-Mediated TLR4 Signaling
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e32359sample for an overnight incubation at 4uC on roller. Agarose
beads were thoroughly washed with cold Lysis Buffer and re-
suspended in 26 Laemmli’s Sample Buffer. The immunoprecip-
itated protein was released after boiling for ten minutes and briefly
centrifuged at 14,000 rpm.
Western and lectin blots
The immunoprecipitated proteins were separated on SDS-
PAGE gels (4–15% Tris-HCl, Bio-Rad) and transferred to
0.45 mm PVDF membranes. , The membranes were blocked with
3% BSA in TBS overnight and blotted with biotinylated Sambucus
nigra lectin (SNA) or Maackia amurensis II lectin (MAAII) (Vector
Laboratory) in 1% BSA in TBS for 1 h, re-blocked for 1 h, then
incubated with streptavidin-HRP in 0.5% BSA in TBS. The
membranes were washed three times in TBST (TBS containing
0.1% Tween20) between each described step. SuperSignal West
Pico Chemiluminescent substrate (Thermo Scientific) was added
to the membranes for 5 minutes prior to exposing them to film
(Kodak). In some cases, the chemiluminescent intensity was
detected by a Fujifilm CCD camera. Fetuin (Sigma) was used as a
positive control and asialofetuin (Sigma) as a negative control for
the lectin binding. Lectin SNA recognizes terminal sialic acids with
an a-2,6 glycosidic linkage. Soluble sialic acids block its binding
and abolished the bands (data not shown), which suggested the
specificity of SNA binding.
Fluorescence resonance energy transfer (FRET) assay
We analyzed the LPS-stimulated association of the TLR-4
receptors by FRET, using CFP or YFP-tagged TLR4 monomers.
The fluorescence spectrum of the CFP protein overlaps the
absorption spectrum of YFP, which makes them a donor-acceptor
pair suitable for estimation of the change in distance between
individual monomers [24,25]. HEK293T cells were transfected
with a mixture of plasmids encoding TLR4-YFP, TLR4-CFP,
CD14, and MD2 and harvested 48 hours later. For NA treatment,
the cells were incubated with 30 mU/ml of NA in PBS at 37uC for
1 hr. After washing, the cells were resuspended in PBS containing
100 mg/ml of cytidine monophosphate to inhibit resialylation by
sialyltransferase. The cells then were transferred to a cuvette and
stimulated with 10 mg/ml of LPS. Emission spectra of the
fluorescent proteins (CFP and YFP) in living cells was measured
every 5 minutes using a FluoroMax 4 spectrofluorimeter (Horiba
Jobin Yvon, USA) equipped with a temperature-controlled cell
holder (PeltierThermostabilization System F-3004). All experi-
ments were undertaken at 37uC. The concentration of cells in all
experiments was 2.5610
6 /ml. Samples were gently shaken in a
cuvette to get homogenous cell distribution before recording the
emission. The fluorescence was excited at 440 nm wavelength at
which both fluorescent proteins (CFP and YFP) absorb light. To
excite YFP protein fluorescence alone we used the 490 nm
wavelength at which only YFP absorbs light. The fluorescence
spectra of the transfected cells were recorded in the spectral range
from 460 nm to 650 nm. The contribution of light scattering to
the fluorescence spectra of transfected cells (background) was
measured using samples containing the non-transfected
HEK293T cells and those values were subtracted from the
fluorescence signals of the sample (Figure S1A).
The FRET effect in HEK293T cells containing CFP- and YFP-
tagged TLR4 proteins was analyzed using the ratio of fluorescence
intensities measured at two wavelengths: 528 nm and 475 nm
(fluorescence maximum of YFP and CFP, respectively) with
excitation undertaken at 440 nm. The ratio F(528)/F(475) is
sensitive to FRET due to strong enhancement of YFP (acceptor)
fluorescence upon energy migration. This FRET ratio was
calculated and plotted against time after stimulation cells with
LPS.
Adenovirus construction
The human neu1o rneu3 sequences were synthesized by
PrimmBiotech (Cambridge, MA) using sequences deposited in
GenBank (NM_000433.3 and NM_006656.5). The Ad-Neu1, Ad-
Neu3, and control Ad-GFP viruses were generated using AdEasy
Adenoviral Vector System (Stratagene, La Jolla, CA) according to
the manufacturer’s recommendation. Briefly, the neu1 and neu3
genes were inserted into a pShuttle-IRES-hrGFP-1 vector using
restriction enzyme digestion and ligation. The neu1, neu3 inserted
or empty shuttle vector was linearized and co-tranformed with
pAdEasy-1 vector into BJ5183 competent cells to generate
recombinant plasmid adeno-neu1, adeno-neu3, or adeno-GFP.
The recombinant plasmids were extracted, and confirmed by Pac I
digestion followed by agarose gel analysis. The plasmids with the
correct recombination by size were further transformed into
XL10-Gold cells for amplification. Sufficient amount of plasmids
were tranfected into AD-293 cells using Lipofectamine (Invitrogen)
for virus packaging. The primary virus stocks were further
amplified in AD-293 cells and their titers quantified with plaque
assay.
Sialidase activity assay
Sialidase activity was assayed by using 29-(4-methylumbelli-
feryl)-a-D-N-acetylneuraminic acid sodium salt hydrate (4-MU-
NANA, Sigma) as the substrate. The lysates from transfected cells
were suspended in 200 ml of 50 mM sodium acetate buffer
(pH 4.4), containing 0.1% Triton X-100 and Protease Inhibitor
Cocktail (Sigma), and 25 ml of 4-MUNANA (2 mM) (Sigma). The
mixtures were briefly vortexed and incubated for 1 hour at 37uC.
The reaction was terminated with 1 ml of glycine buffer (pH 10.3)
containing 0.133 M glycine, 60 mM NaCl and 42 mM Na2CO3.
After the mixtures were centrifuged, the supernatants were
collected and dispended into 96 well microplate (Costar) to
measure the fluorescence intensity by Fluoroskan Ascent FL
(Thermo Electron Corporation). The amount of free 4-Mu in each
samples were interpolated with the intensities from a serial dilution
of known concentration of 4-Mu (Sigma) using GraphPad Prism 4
(GraphPad software, Inc. La Jolla, CA).
Statistical analysis
Statistical significance was calculated using Student’s t test in
Microsoft Excel; p values smaller than 0.05 were considered
significant.
Results
1. Desialylation enhances LPS-induced NFkB signaling in
HEK293T cells transfected with TLR4 complex
Since we previously observed that bacterial NA treatment of
intact human PBMC led to a synergistic increase in cytokine
expression with LPS stimulation [16], we hypothesized that
desialylation of the TLR4 complex contributed to the TLR4
signaling in response to bacterial LPS. We therefore utilized an
established luciferase reporter gene transfection system [16] and
studied the NFkB activation by luciferase activity detected in cell
lysates. HEK293T cells alone, which lack endogenous TLR4
receptors, do not respond to LPS stimulation (data not shown).
Following LPS stimulation, luciferase activity in TLR4/MD2/
CD14-transfected cells increased in response to LPS dose-
dependently (Figure 1A). Correspondingly, IL-8 production in
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activities (data not shown).
To study the effect of NA treatment, the transfected cells were
treated with NA before LPS stimulation. As shown in Figure 1B,
the NA-treated transfected cells had a nearly 50% increase in the
luciferase activity in response to LPS compared to those with no
NA treatment (Figure 1B, p,0.05). IL-8 production also increased
on LPS-stimulated cells with NA treatment (Figure 1C, p,0.05).
To exclude the possibility that the enhanced NFkB activation
was due to additive activation by the impurities in the enzyme
preparation, we treated the cells with NA in the presence of 2-
DN—a neuraminidase inhibitor or with heat-inactivated NA.
While increased from transfected cells with NA treatment, the
luciferase activities from similarly treated cells in the presence of 2-
DN is comparable to that from cells which did not receive NA
treatment (Figure 1D). Heat-inactivated NA also failed to enhance
the TLR4 signaling in response to LPS stimulation (Figure 1D).
These results confirm that the enhancement in TLR4 signaling
was dependent on the catalytic activity of NA which can be
abolished by either inhibitor or heat inactivation.
2. Requirement of MD2 in TLR4 signaling
The TLR4 receptor complex consists of three critical compo-
nents, TLR4, MD2, and CD14, for its optimal signaling. When
HEK293T cells were transfected with the plasmid mixture without
MD2, no luciferase activity was detected after LPS stimulation
(Figure 2A). Since it was reported that the soluble form of MD2
(sMD2) supported LPS-mediated TLR4 signaling by recruiting
LPS to the TLR4 complex and activated the downstream signaling
[6,23], we tested if we could supplement sMD2 and restore the
responses of TLR4/CD14-transfected cells to LPS. E. coli-derived
recombinant human MD2 (rhMD2, R&D) was added to the
culture of TLR4/CD14-transfected cells before LPS stimulation.
Over a wide range of concentrations (up to 2 mg/ml), the rhMD2
did not restore the luciferase activity in lysates of TLR4/CD14-
transfected cells with LPS stimulation (Figure 2B). This finding was
consistent with previous reports that MD2 was highly-glycosylated
[6,26] and that mutations at glycosylation sites abolished the
TLR4 signaling [6,26]. Since commercially available rhMD2 is
made in E. coli, it is deficient in glycosylation.
Supernatant from MD2-transfected HEK293T cells was tested
as a source of sMD2 to overcome the problem with bacterial-
expressed MD-2. TLR4/CD14-transfected cells were supplement-
ed with sMD2 before LPS stimulation. A significant amount of
luciferase activity was detected, even though it was lower than that
of TLR4/MD2/CD14-transfected cells (Figure 2C). As a control,
little luciferase activity was detected with supplementation of
supernatant from mock-transfected cells (pcDNA) (Figure 2C).
Thus, our data confirmed that addition of sMD2 partially restored
TLR4 signaling in reconstituted culture, and suggested that, like
for TLR4 itself, appropriate glycosylation of MD2 was required
for TLR4 signaling.
Although we were able to restore LPS-mediated signaling with
addition of MD2-containing supernatant, the strength of that
signal never approached that of the TLR4/MD2/CD14-trans-
fected cells. Luciferase activity did not change using increasing
amounts of MD2-containing supernatant in a wide range (data not
shown) suggesting that the concentration of MD2 was not the
Figure 1. Neuraminidase treatment enhances cell response to LPS stimulation. HEK293T cells were transfected with a mixture of
expression vectors encoding TLR4-YFP, MD2-FLAG, CD14, and firefly and Renilla luciferase genes. After 48 h, the transfected cells were stimulated
with LPS (1 to 10 ng/ml) for 16 h and firefly vs. renilla luciferase activities were measured in cell lysates (A). Transfected cells were treated with C.
perfringens neuraminidase (NA) or mock-treated (PBS) for one hour at 37uC, stimulated with LPS (1 ng/ml) or no-stimulation (medium) for 16 h, and
the lysates were evaluated for luciferase activity (B), and production of IL-8 (C). Transfected cells were mock-treated (PBS) or treated with NA alone,
NA with specific inhibitor (NA+2-DN), or heat-inactivated NA (DNA), stimulated with LPS (1 ng/ml) for 16 h, and the lysates were evaluated for
luciferase activity (D). Results shown are representative of data from at least 3 independent experiments, each with similar results. RLU (relative
luciferase units) represent each sample’s firefly vs. renilla luciferase activity.
doi:10.1371/journal.pone.0032359.g001
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culture. Indeed, it has been reported that picomolar amounts of
sMD2 is sufficient to induce LPS-mediated TLR4 complex
activation [23]. To further address this question, we purified
sMD2 from the culture supernatant of MD2-transfected cells using
an anti-FLAG affinity column. Again, supplementation of up to
2 ug/ml purified MD2 into TLR4/CD14-transfected cells
restored the LPS-induced NFkB activation partially (Figure 2D).
This result suggests that exogenous sMD2 could restore the TLR4
signaling.
3. Effect of mutations at glycosylation sites on the ability
of TLR4 to mediate LPS-induced activation
The TLR4 ectodomain contains nine N-linked glycosylation sites
which are critical for TLR4 receptor function [6]. To examine the
importance of glycosylation for TLR4 signaling, we used site-
directed mutagenesis to introduce alanine substitutions of aspara-
gines (N) at positions 35, 173, and 205 into TLR4-YFP. These sites
were chosen since compromised LPS signaling exerted by these
mutations could not be attributed to reductions in their expression
levels compared to wild-type TLR4 [6]. To test the impact of these
mutations on TLR4 signaling, CD14/MD2 co-receptors were
overexpressed in HEK293T cells along with either wild-type or
mutant TLR4 versions, and LPS-mediated activation of co-
transfected NF-kB luciferase reporter was determined. We found
that the N35A/N173A double glycosylation mutants exhibited
LPS-mediated NF-kB reporter activation reduced by ,75%, and
the triple mutant N35A/N173A/N205A exerted ,83% reduction
(Figure 3). Mutagenesis of single N-linked glycosylation sites did not
affect LPS-mediated NF-kB activation (data not shown and [6]), while
P714H TLR4-YFP, which was made to mimic the non-signaling
Figure 2. Requirement of MD2 in TLR4 signaling. HEK293T cells were transfected with a mixture of all plasmids as in Figure 1 (TLR4/CD14/
MD2), plasmids encoding only TLR4 and CD14 (TLR4/CD14), or control plasmid (pcDNA), stimulated with LPS (1 ng/ml) for 16 h and the lysates were
evaluated for luciferase activity (A). TLR4/CD14-transfected HEK293T cells were stimulated with LPS in culture in the presence of increasing amounto f
recombinant human MD2, and the lysates were evaluated for luciferase activity (B). Culture supernatants (SNT) from MD2- or empty vector- (pcDNA)
transfected cells were added to TLR4/CD14-transfected cells prior to LPS stimulation and luciferase activity was determined in cell lysates (C). A
specific amount of affinity-purified sMD2 was added in culture media of TLR4/CD14-transfected cells before LPS stimulation (dark bars). TLR4/CD14/
MD2-transfected cells with LPS stimulation were included as positive control (open bars) (D). Results shown are representative of data from at least 3
independent experiments, each with similar results.
doi:10.1371/journal.pone.0032359.g002
Figure 3. Effect of P714H, N35A/N173A, and N35A/N173A/
N205A mutations on the ability of TLR4 to mediate LPS-induced
activation. HEK293T cells were co-transfected with expression vectors
encoding wild type TLR4 (WT) or P714H, N35A/N173A, and N35A/N173A/
N205AmutantsalongwithpEFBOS-MD2,pCDNA3-CD14,pELAM-luc,and
pTK-Renilla-luc. Transfected cells were stimulated with LPS for 6 h, and
firefly vs. renilla luciferase activities were measured in cell lysates. Data
were processed using Student t-test. *p,0.005; **p,0.05 (vs. WT).
doi:10.1371/journal.pone.0032359.g003
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mice, showed complete signaling deficiency (Figure 3A). These data
indicate the importance of N-linked glycosylation for TLR4 signaling
capacity.
4. Sialylation of TLR4 and MD2
Even though it was known that TLR4 was glycosylated and N-
linked glycosylation was important in its signaling, the glycan moiety is
still unknown. Since our previous studies [16] suggested that TLR4
complex may contain sialic acid, we determined whether TLR4 and
MD2 were sialylated using lectin blot technique established in our
laboratory [14]. Lectins are a group of proteins that bind specifically to
different glycoconjugates. SNA and MAAII recognize terminal sialic
acid in a-2,6- or a-2,3-linkage respectively. The His-tagged
recombinant human TLR4/MD2 mixture expressed in mammalian
NS0 cells (R&D) was separated on SDS-PAGE, and blotted with SNA
and MAAII. One band at 105 KD was identified (Figure 4A) with
SNA, which corresponds to the reported size of recombinant TLR4.
Anti-His antibody recognized the same size band in Western blot, but
no band in this range was detected with MAAII blotting (Figure 4A).
Figure 4. Sialylation of TLR4 and MD2. Recombinant human TLR4-His/MD2-His proteins expressed in the mammalian NS0 cell line were
separated by SDS-PAGE and analyzed on immunoblot for binding to lectin SNA, MAAII and to anti-His antibody (A). Recombinant human TLR4-His/
MD2-His expressed in NS0 cells (lane 1) or recombinant human MD2-His expressed in E. coli (lane 2) were separated by SDS-PAGE and probed by
lectin blot with SNA (left) and on immunoblot with anti-His antibody (right) (B). Recombinant human CD14 (lane 1) were separated by SDS-PAGE and
probed by lectin blot with SNA (left) and MAAII (right). The highly sialylated glycoprotein, fetuin (lane 2) and asialofetuin (lane 3) were included as
positive and negative controls respectively (C). HEK293T cells were transfected with control pcDNA, or plasmids encoding TLR4-YFP alone or with
MD2 and CD14 expression plasmids, and proteins from cell lysates were immunoprecipitated with ant-GFP antibody and probed on immunoblot
with either anti-GFP antibody (top) or SNA (bottom) (D). Proteins from the medium of MD2-transfected cells were immunoprecipitated with anti-
FLAG antibody and probed on immunoblot with anti-FLAG antibody (left) or SNA (right) (E). The expected molecular weights of MD2 and TLR4 are
indicated by arrows. Results shown are representative of data from at least 2 independent experiments, each with similar results.
doi:10.1371/journal.pone.0032359.g004
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but was not observed in the lane with the rhMD2 expressed from
E. coli. Anti-His antibody recognized a same size and another
lower MW (25 KD) band in Western blot, perhaps two variant
forms of MD2 (Figure 4B) previously observed [6]. No band in this
range was detected with MAAII blotting (data not shown). Thus,
our data confirm that both recombinant TLR4 and MD2
expressed in mammalian NS0 cells contained a-2,6-linked sialic
acid residues.
CD14 is known to be glycosylated, but the glycan species have
not been identified [27 28]. We therefore examined the sialylation
status of recombinant soluble human (rh) CD14 (R&D). Using the
lectin blot technique we observed a weak but discernible band with
MAAII but not with SNA, which indicates that CD14 is sialylated
with a-2,3 glycosidic linkage (Figure 4C). Fetuin and asialofetuin
were used as positive and negative controls respectively for the
lectins.
To verify the TLR4-YFP in our transfected HEK293T cells was
sialylated, we immunoprecipitated the TLR4 complex from the
lysate of transfected cells with anti-GFP antibody and separated
the protein on SDS-PAGE gel. The TLR4-YFP fusion protein was
first located by blotting with anti-GFP antibody. A major band at
150 KD was identified from TLR4- or TLR4/MD2/CD14-
transfected cell lysate but was absent from pcDNA-transfected
cells. (Figure 4D, top panel). When blotted with SNA, the same
size band at 150 KD was recognized (Figure 4D, bottom). These
data suggested the TLR4-YFP from cell lysates was also sialylated
with a-2,6-linkage.
Similarly, MD2-FLAG was immunoprecipitated from the
culture supernatants of MD2-transfected cells with anti-FLAG
antibody and separated on SDS-PAGE. Three bands at 15–
25 KD were identified (Figure 4E, left) when blotting with anti-
FLAG antibody, which corresponds to three variations in
glycosylation previously reported [6]. When blotted with SNA,
one band at 25 KD was identified (Figure 4E, right). No band in
this range was detected with MAAII blotting (data not shown).
These data suggest that at least one isoform of glycosylated MD2
contained terminal sialic acid with a-2,6-linkage.
5. Optimal signaling when both TLR4/CD14-transfected
cells and sMD2 are treated with neuraminidase
As removal of sialyl residues from the transfected cells enhanced
LPS-mediated signaling, we determined whether desialylation of
either or both TLR4/CD14 on cells and MD2 contributed to the
signaling enhancement. We treated sMD2 with NA and added it
into the above reconstituted culture. Heat-inactivated NA was
used to treat supernatant as a control. Addition of desialylated
sMD2 restored a moderate but significant NFkB signal unlike the
case with the MD2 treated with heat-inactivated NA (Figure 5A,
p=0.036). This result suggested that desialylation of sMD2
enhanced LPS-induced TLR4 signaling.
To determine whether TLR4/CD14 desialylation contributes
to the signaling enhancement, we treated TLR4/CD14-transfect-
ed cells with NA or heat-inactivated NA. After sMD2 reconsti-
tution, NA-treated cells had stronger NFkB activation than
untreated cells after sMD2 reconstitution. Given these findings
we then asked whether optimal signaling could be obtained with
both TLR4/CD14 on the cells and sMD2 treated with NA before
reconstitution. As anticipated, the highest NFkB activation was
observed when both cells and supernatant were treated with NA
(the second histogram in Figure 5B); suboptimal enhancement was
observed with desialylation of either TLR4/CD14-bearing cells
(the fourth histogram) or MD2-containing supernatant (the third
histogram in Figure 5B). Desialylation of cells had a better result
Figure 5. Optimal LPS-induced signaling when both TLR4/
CD14 and MD2 treated with neuraminidase. HEK293T cells that
were transfected as in Figure 2 and TLR4/CD14-transfected cells were
supplemented with NA-treated SNT from MD2 transfected cells (MD2*),
heated-inactivated NA-treated SNT (MD2**), or SNT from empty vector
transfected cells (pcDNA) before LPS stimulation (5 ng/ml). Cell lysates
were harvested after 16 h for reporter assay (A). TLR4/CD14-transfected
HEK293T cells were treated with NA, heat-inactivated NA (DNA), or were
untreated (-) for one hour at 37uC, stimulated with LPS (5 ng/ml) for
16 h in the presence of SNT from MD2 transfected cells (sMD2), which
had been pre-treated with NA agarose (NA), heated-inactivated NA
agarose (DNA), or were untreated, and luciferase activities were
determined in cell lysates (B). TLR4/MD2-transfected HEK293T cells
were supplemented with NA treated recombinant human CD14
(rhCD14[NA]), untreated CD14 (rhCD14), or medium (none) prior to
LPS stimulation (1–5 ng/ml). Cell lysates were harvested after 16 h for
reporter assay (C). Results shown are representative of data from at least
3 independent experiments, each with similar results.
doi:10.1371/journal.pone.0032359.g005
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desialylation of both is needed for optimal signaling. The luciferase
activity following LPS treatment of both TLR4/CD14-transfected
cells and sMD2, each treated with heat-inactivated NA, was
similar to that of cells and sMD2 not exposed to NA (Figure 5B,
fifth histogram vs. first histogram).
Since we demonstrated that desialylation of HEK293 cells
transfected with plasmids encoding TLR4 and CD14 resulted in a
marked increase in luciferase activity (Figure 5B), we next
dissected the relative contribution of the TLR4 and CD14
components, each of which is sialylated, to the NA-enhanced
signal. CD14 may be present either as a membrane-bound protein
on the surface of cells, or as a circulating, soluble protein [28,29].
HEK293T cells were transfected with TLR4/MD2 (i.e. in the
absence of CD14) and supplemented with soluble, rhCD14 that
was treated with or without NA before addition to the culture
prior to LPS stimulation for luciferase assay. TLR4/MD2-
transfected cells exhibited decreased luciferase activity in the
absence of exogenous CD14 (Figure 5C). The minimal response in
the absence of transfection of cells with the CD14-encoding
plasmid may be due to CD14 that was present in the culture
medium, as previously reported [21].. Addition of rhCD14 further
increased the luciferase activity from TLR4/MD2-transfected cells
(Figure 5C); however, there was no significant difference between
the addition of NA-treated and untreated rhCD14 (Figure 5C) or
with heat-inactivated NA-treated CD14 (data not shown). This
suggests that the moderate level of sialylation on CD14 plays no
role in the NA-enhanced signaling through TLR4.
6. Dimerization of TLR4 receptor with LPS stimulation
During LPS stimulation, dimerization of TLR4 must occur
(including the interaction with MD2-LPS) for MyD88 recruitment
and triggering of downstream signaling [30,31]. We speculated that
desialylation might facilitate TLR4 dimerization and therefore
enhance LPS-induced TLR4 signaling. To addressthisquestion,we
co-transfected HEK293T cells with YFP- and FLAG-tagged TLR4
plasmidsalongwith CD14andMD2andassayed forthe interaction
of the two tagged TLR4 molecules by immunoprecipitating YFP-
tagged TLR4 from lysates of tranfected cells (by anti-GFP antibody)
and immunoblotting the FLAG-tagged protein . A small fraction of
FLAG-tagged protein could be detected after GFP immunoprecip-
itation in the absence of LPS stimulation, which increased after
30 minutes of LPS stimulation (Figure 6A). This time-dependent
Figure 6. NA treatment of TLR4-expressing HEK293T cells
enhanced TLR4 dimerization. HEK293T cells were transfected with
mixture of expression vectors encoding TLR4-YFP, TLR4-FLAG, MD2-HA,
and CD14 for two days. At indicated time points after stimulation with
LPS (10 mg/ml), cell lysates were harvested and proteins were
immunoprecipitated with anti-GFP antibody, separated on SDS-PAGE
gels and probed on immunoblot with either anti-FLAG or anti-GFP
antibodies to reveal the individual tagged TLR4 protein (A). Transfected
cells were treated with either NA or PBS (as control) for 1 hour before
LPS stimulation and processed as above (B). The captured images were
analyzed using ImageJ (NIH, USA) and the relative intensities were
obtained by dividing the mean intensity of the bands on Western blot
using anti-FLAG antibody over that using anti-GFP blot. HEK293T cells
were transfected with mixture of plasmids encoding TLR4-CFP, TLR4-
YFP, MD2-HA, and CD14 and were maintained in culture for two days,
re-suspended, and treated with NA (30 mU/ml, open circles) or PBS
(filled symbols) for 1 hr. Cells were transferred to a cuvette, where they
were stimulated with LPS (10 mg/ml, circles) or control PBS (triangles).
The fluorescence spectrum for each sample was recorded at different
time points, and the F528/F475 ratio was plotted (C). Results shown are
representative of data from at least 3 independent experiments.
doi:10.1371/journal.pone.0032359.g006
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increased the dimerization of two tagged TLR4.
To study the effect of NA treatment in LPS-induced TLR4
dimerization, transfected cells were treated with NA (30 mU/ml)
or PBS (untreated control) for 1 h prior to LPS stimulation.
Compared to the untreated group (PBS), earlier dimerization was
seen in the NA-treated cells at 15 minutes and the TLR4
dimerization was greater at 60 minutes after LPS stimulation
(Figure 6B).
FRET analysis using TLR4 protein tagged with fluorescent
proteins (CFP and YFP) at the C-terminal end further confirmed
that TLR4 dimerization occurred and was enhanced with NA
treatment. HEK293T cells were transfected with plasmids
encoding TLR4-YFP, TLR4-CFP, MD2, and CD14 and
stimulated with LPS. Formation of CFP- and YFP-tagged TLR4
heterodimers was then measured using FRET (Supporting
information S1, Figure S1). After LPS addition, the FRET signal
from CFP/YFP cells exponentially increased and reached
saturation (equilibrium) at .20 min (Figure 6C), while cells
without LPS stimulation (control) showed only a slight non-specific
increase in FRET ratio with time. The observed exponential
change in FRET signal exhibited low-rate kinetics (characteristic
time of kinetics is about 20 min) of TLR4 dimerization, which
could be explained by slow lateral diffusion of TLR4 monomers
within a viscous plasma membrane. It should be noted that the
TLR4 dimer is a dynamic system which is in equilibrium with the
monomers, with the state of equilibrium depending on the
dimerization constant. The value of the FRET signal reflects not
only the interaction between TLR4 monomers, but also the state
of equilibrium, i.e. affinity of the proteins to each other. We
observed a similar effect of the binding equilibrium on the
asymptotic FRET value for protein/DNA interactions [32,33].
The rates of TLR4 dimerizaton after LPS stimulation of NA
treated cells and non-treated cells were similar, but the asymptotic
value of the FRET signal for NA-treated cells was significantly
greater as compared to non-treated cells. The increase in FRET
signal for NA treated cells in a state of equilibrium, (t.40 min,)
could be explained by the shift of equilibrium to dimers in the
binding reaction, TLR4+TLR4?(TLR4)2, i.e. the affinity of NA-
treated TLR4 proteins to each other is greater as compared to
non-treated TLR4 proteins. It also assumes that NA treatment of
cells could modify the structure (desialylation) of TLR4 and cause
tighter contact between components of the dimer.
7. 2-DN inhibits TLR4 signaling
Mammalian sialidases share homolog and functional similarity
with bacterial or viral neuraminidases [34,35]. We speculated that
desialylation by endogenous human sialidases affects TLR4
signaling similar to what we observed with bacterial neuramini-
dase demonstrated above. Four human sialidases had been
identified, with particular cellular localizations, and perhaps
different cellular functions [35]. Lysosomal sialidase (Neu1) is the
most abundant sialidase which associates with other proteins to
form a multienzyme complex in lysosomes [36]. It is also expressed
on the surface of diverse types of cells [37–40]. Membrane-
associated sialidase (Neu3) preferentially desialylates gangliosides
and perhaps many surface glycoproteins [41,42]. To confirm the
ability of 2-DN to inhibit sialidase, we first overexpressed Neu1
and Neu3 with contructs of recombinant adenovirus expressing
human Neu1 (Ad-Neu1) or Neu3 (Ad-Neu3). To verify the
sialidase activities, we performed a 4-MUNANA assay after
HEK293T cells were infected with recombinant adenovirus.
Compared to a mock control (Ad-GFP), both Ad-Neu1 and Ad-
Neu3 infected cells had significantly higher enzymatic activities,
which were decreased by the neuraminidase inhibitor 2-DN at
least 10-fold (Figure 7A).
To test the effect of overexpression of sialidase on LPS-induced
TLR4 signalling, the TLR4/CD14/MD2-transfected cells were
infected with various recombinant adenoviruses and stimulated
with LPS. Compared to Ad-GFP, Ad-Neu1, but not Ad-Neu3
infected cells had higher NFkB activation in response to LPS
stimulation (Figure 7B). Therefore, overexpression of human Neu1
enhanced cell responses to LPS.
Since HEK293T cells also demonstrated endogenous sialidase
activity (Figure 7A), we speculated that the neuraminidase
Figure 7. Inhibition of endogenous sialidase activity sup-
pressed LPS-induced NFkB activation in HEK cells. HEK293T
cells were infected with recombinant adenoviruses expressing human
Neu1 (Ad-Neu1) or Neu3 (Ad-Neu3), or with virus containing empty
vector (Ad-GFP) and sialidase activity from cell lysates was assayed
using 4-MUNANA as substrate in the absence or presence of the
sialidase inhibitor 2-DN (250 mg/ml) (A). TLR4/CD14/MD2-transfected
HEK293T cells were further infected with Ad-Neu1, Ad-Neu3 or Ad-GFP,
for 2 days, stimulated with LPS (1 ng/ml) for 16 h, and evaluated for
luciferase activity (B). TLR4/CD14/MD2-transfected HEK293T cells were
incubated with 2-DN (250 mg/ml) or KDO (250 mg/ml) for 2 days, and
stimulated with different concentrations of LPS for 16 h prior to analysis
of cell lysates for luciferase activity (C). Results shown are representative
of data from at least 3 independent experiments, each with similar
results. ND: not done.
doi:10.1371/journal.pone.0032359.g007
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complex by endogenous sialidase and therefore decrease the cells’
response to LPS. The TLR4/MD2/CD14-transfected cells were
incubated with 2-DN or KDO (as mock control) before and during
LPS stimulation. The presence of 2-DN decreased the luciferase
activities in the lysates of the transfected cells in response to LPS
stimulation significantly (Figure 7C). This suggested that desialyla-
tion by endogenous sialidase also optimized TLR4 signaling in the
same manner as bacterial NA and inhibition of sialidase activities
lowered LPS-induced NFkB activation.
Discussion
Our earlier finding that NA pre-treatment of human PBMCs
enhanced their pro-inflammatory cytokine response following a
subsequent stimulation with LPS suggested that the TLR4
receptor complex was sialylated, and that modulation of sialyl
residues on the TLR4 might affect TLR4-mediated LPS signaling
[16]. In the present study we show that two components of the
TLR4 complex, TLR4 and MD2, have sialyl residues in an a-2,6
glycosidic linkage and that NA treatment of both MD2 and TLR4
independently and additively enhance TLR4 complex-initiated
signaling. Human CD14 was weakly sialylated in a a-2,3 glycosidic
linkage. LPS-induced NFkB activation was increased with
overexpression of human cytoplasmic sialidase (Neu1) and
endogenous sialidase activity was suppressed with 2-DN, suggest-
ing a role for endogenous HEK293T cell sialidase in optimal
TLR4 signaling. Thus, modulation of the sialyl status of these
molecules may represent an additional mechanism by which their
activity is regulated.
Using a previously described experimental system in which
HEK293T cells that lack TLR4 are transfected with plasmids
encoding TLR4, MD2 and CD14, we were able to recapitulate
the requirements for LPS signaling. Using either a luciferase NFkB
dependent reporter system or IL-8 expression to monitor the
response, we found that when transfected with TLR4/CD14/
MD2, LPS treatment induced these cells to respond, and that NA
pretreatment increased this response. This increased response was
abrogated either by addition of a NA inhibitor, 2 DN, or heat
inactivation of NA. Our reconstituted HEK293T experimental
system was also capable of demonstrating the importance of
glycosylated MD2.
Using endoglycosidase treatment and site-directed mutagenesis
of N-linked glycosylation sites, Correia and Ulevitch reported that
N-linked glycosylation sites on both MD2 and TLR4 were
essential LPS signaling [6], but did not identify the glycans that
were important or suggest whether modification of these
glycosylation sites might contribute to the regulation of their
response. In our studies, when the plasmid for MD2 was omitted
from the transfection of HEK293T cells, LPS was unable to
induce a luciferase response, as previously observed by Visentin et
al [43]. Supplementation of the TLR4/CD14-transfected
HEK293T cell cultures with a non-glycosylated rMD2 made in
prokaryotic cells was unable to restore the activity (Figure 2B);
however, addition of culture supernatants from MD-2 transfected
cells or affinity purified protein from these supernatants that were
each glycosylated reconstituted HEK293T cell responsiveness to
LPS . Picomolar amounts of ectopically-tagged sMD2 from
transfected HEK293T cells were reported to activate TLR4
[23]. Therefore, glycosylation of MD2 is required for TLR4
signaling.
MD2 was originally discovered by its sequence homology with
MD-1, a protein associated with a B cell homologue of TLR4, RP
105 [44]. It is an Ig domain-folded protein with a deep
hydrophobic pocket. CD14 is a membrane-bound protein
expressed on myeloid cells and is present in plasma as a soluble
protein. It functions as a soluble LPS receptor that recognizes LPS
bound to LPS binding protein- and transfers the monomeric LPS
to MD2 which then binds to TLR4 [28]. Thus, MD2 bridges the
recognition of LPS by LBP and CD14 to the activation of TLR4
through the high-affinity, non-covalent binding to the N-terminal
ectodomain of TLR4 [45]. Soluble MD2 (sMD2) in supernatants
of MD2-transfected HEK293T cells represents a heterogenous
collection of unstable and mainly inactive oligomers; however,
only the MD2 monomer is capable of binding the LPS and
activating TLR4 [45,46].
Exogenous soluble MD2 was not able to fully reconstitute the
LPS responsiveness that we measured when HEK293T cells were
transfected with TLR4/MD2 /CD14. Earlier studies suggested
that MD2 facilitates the expression of TLR4 on the cell surface
[47]. Thus the lower response to the addition of sMD2 could be
attributed to the reduced expression of TLR4 on the HEK293T
surface, although another study challenges that conclusion [48].
Alternatively, since sMD2 exists primarily as inactive, unstable
multimers, there might not have been a sufficient number of MD2
monomers added to provide the required activity. Even when
added as affinity-purified protein from the culture supernatants,
we observed a plateau of responsiveness with increasing amounts
of MD2 protein which suggests that the problem could have been
the activity of the sMD2 and not the amount of protein in the
supernatant.
We also show that N-linked glycosylation of TLR4 is required
for TLR4-mediated signaling and that TLR4 has a-2,6 sialyl
residues. Since it is not possible to desialylate only TLR4 on
primary cells without affecting other cell surface molecules, we
could not directly prove the effect of desialylation of TLR4;
however, several lines of evidence support this conclusion. First,
desialylating cells without MD2, one component of the TLR4
complex, did not induce any signaling by LPS, which suggests that
it is TLR4-mediated signaling (data not shown). Secondly,
desialylation of cells alone, without LPS stimulation, induced only
minor signaling. Thirdly, desialylation increased TLR4 dimeriza-
tion which is required to initiate its downstream signaling cascade.
When the TLR4/CD14 complex and MD2 in HEK293T cell
cultures were independently treated with NA, removal of sialyl
residues from each of these components contributed to the
optimally enhanced LPS responsiveness (Figure 5) with the sialic
acid modulation of TLR4/CD14 having a more critical role than
desialylation of sMD2. The lesser effect of desialylation on sMD2
may be attributable in part to our finding (Figure 4D) that only
one of the three previously described protein isoforms of MD2 is
recognized by the lectin, SNA. Thus, it is possible that in addition
to its a-2,6 sialyl glycoform, MD2 may have additional glycosyl
species critical to LPS-mediated signaling. We are investigating
this possibility in our laboratory.
Human CD14 is predicted to have four N-linked glycosylation
sites [49,27] as well as O-linked glycans [28]. The glycan species
that may be associated with CD14 have yet to be identified. We
find that rsCD14 has an a-2,3-linked sialyl residue that does not
appear to contribute to the NA-enhanced LPS-initiated signaling
through TLR4 (Fig 5C). This suggests that, like MD-2, other
glycans may play a more important role in contribution to the
structure and function of CD14.
The seeming contradiction that N-linked glycosylation of TLR4
and MD2 is required for their functional activity, yet removal of
sialyl residues enhances their activity can be explained by the fact
that sialyl residues often are present at a terminal position on
glycans. Removal of these terminal sialyl residues by sialidases (or
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or conformation of these glycans and affect their functional
activity. Thus while glycans are critical to TLR4 complex
function, modification of sialyl residues on those glycans provide
an additional measure of regulation. Further, it is likely that the
removal of terminal sialyl residues exposes subterminal galactose
residues on these glycans which may then serve as targets for
galectins that may have either pro- or anti-inflammatory
properties [50].
Appropriate glycosylation of proteins might be crucial for the
interaction of LPS with elements of TLR4 complex. It has been
suggested [48] that the interaction of MD2 and TLR4 may induce
a conformational change that leads to the dimerization required
for signaling. Our data suggest that the terminal sialic acids on the
glycan may have a negative effect on TLR4 signaling. With its
negative charge, sialic acid might hinder the interaction between
TLR4 monomers or the MD2-LPS interaction with the TLR4
ectodomain. Removal of the negatively charged sialic acid on the
molecule surface, may facilitate MD2-TLR4 interaction and/or
TLR4-TLR4 dimerization (Figure 6B, C). In the absence of
identifying the size and nature of the glycan structures on TLR4, it
would be difficult to predict how glycosylation might affect the
published structure of this molecule and its interaction with MD-2
and ligand [51,52].
LPS is believed to bind directly to MD2, and this LPS/MD2
complex binds to the TLR4 ectodomain which results in TLR4
dimerization and ultimately intracellular signaling. In the current
study we did not evaluate whether removal of sialyl residues of
MD2 enhanced the binding of LPS to MD2; however, MD2 is
unstable in the absence of LPS binding [53]. We now show by
both co-immunoprecipitation experiments and FRET analysis that
LPS treatment initiates TLR4 dimerization and that NA
pretreatment facilitates this interaction.
Finally we suggest that human sialidase is capable of mediating
these NA-enhanced responses. While HEK293T cells have some
sialidase activity (Figure 7A), co-expression of Neu1 and 3 with the
TLR4 complex resulted in increased HEK293T cells sialidase
activity that was inhibitible by 2DN, the sialidase inhibitor
(Figure 7B, C). In the absence of exogenous NA, LPS treatment
induced a luciferase response that was inhibitable by 2DN, but not
KDO. Thus, either Neu1 or Neu3 or an endogenous HEK293T
sialidase (Figure 7C) could be a source of the sialic acid modulation
in the TLR4 receptor complex. We previously showed in human
PMNs that upon stimulation, sialidase activity was mobilized from
secondary granules within the cell to the plasma membrane where
it became an integral plasma membrane protein capable of
removing sialyl residues from glycoconjugates on its own
(autocrine) or adjacent (paracrine) cell surfaces [11,12]. These
studies were completed before the identification of the 4 neu
isoforms. In a recently published study we were able to show that
upon activation endogenous PMN sialidase activity could play a
role in leukocyte trafficking by unmasking an activation epitope on
b2 integrins and that Neu1 co-localized with the b2 integrin on
fluorescence microscopy [14]. Further, the integrin binding
partner, ICAM-1, on endothelial cells could be ‘‘activated’’ for
enhanced b2 integrin binding by removal of sialyl residues from
ICAM-1. Together, these data suggest that with cell activation,
sialidase mobilization, perhaps Neu 1, could be a source of sialyl
residue modification.
Since our initial observation that NA pretreatment of human
PBMCs enhanced the responsiveness to LPS, Amith et al later
reported that TLR4 was sialylated with a a-2,3 linkage and
showed Neu1 colocalization with TLR4 by fluorescent microscopy
[40,54]. In neither study was the role of glycosylation of MD2 or
CD14 examined. Our study differs from this report by observing
that both MD2 and TLR4 are required for signaling and both are
sialylated in an a-2,6, not an a-2,3 glycosidic linkage. Further, we
demonstrate dimerization of TLR4 monomers is enhanced by
removal of sialyl residues by two different methods (Figure 6).
These studies demonstrate that modification of protein
glycosylation is a rapid, additional mechanism by which cells
regulate the activity of their receptor and other surface
glycoconjugates important to immune responses. Further, it is
likely that microbial pathogens that express NA may take
advantage of these regulatory mechanisms to subvert the host
immune response as part of their virulence strategy. This
possibility offers a rich opportunity for further investigation and
therapeutic targeting.
Supporting Information
Figure S1 Dimerization of TLR4 receptors can be
effectively measured using the FRET approach. (A) The
fluorescence spectra of HEK293T cells transfected with TLR4-
YFP (line 1). The background signal was measured using the
control non-transfected cells (line 2). The fluorescence spectrum of
the TLR4-YFP cells was corrected by subtracting the background
signal (line3). Fluorescence was excited at 490 nm. (B) The
fluorescence spectra of HEK293T cells, transfected with either
TLR4-YFP, TLR4-CFP, or both TLR4-YFP and TLR4-CFP,
showed the characteristic FRET change with time after LPS
stimulation. With excitation at 440 nm, the fluorescence spectra of
CFP and YFP were spectrally separated: CFP emission had
maximum at 475 nm and YFP at 528 nm. After LPS stimulation,
excitation at 440 nm resulted in a YFP (acceptor) emission
increase, indicating protein association.
(TIF)
Supporting Information S1 Supporting methods.
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